📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lentiviral Vectors with Cellular Promoters Correct Anemia and Lethal Bone Marrow Failure in a Mouse Model for Diamond-Blackfan Anemia. (2017)

First Author: Debnath S

Attributed to: Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2017.04.002

PubMed Identifier: 28434866

Publication URI: http://europepmc.org/abstract/MED/28434866

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 8

ISSN: 1525-0016